Abstract Cyclopeptides have emerged as promising candidates for drug development. However, owing to the scarcity of efficient cyclization strategies for natural peptides, the development of diverse cyclopeptides remains a formidable challenge. In this study, a variety of macrocyclic peptides featuring (thio)urea bridges are developed through the site-selective lysine‑lysine crosslinking of native peptides, employing N, N’-carbonyldiimidazole or N, N’-thiocarbonyldiimidazole as bridging reagents.
Peiru Chen
As seen in:
Nature,
Wiley Online Library,
Frontiers,
MDPI,
Taylor & Francis Online,
ACS Publications,
BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Peiru
Contact Peiru, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack